Benzocaine Market turns its focus towards the next wave of big opportunities with the ongoing COVID-19 prevalence to be valued at US$ 155.3 MILLION 2028 | TCI Chemicals (India) Pvt. Ltd, Merck KGaA, ACETO Corporation, Alfa Aesar

Benzocaine Market turns its focus towards the next wave of big opportunities with the ongoing COVID-19 prevalence and wider acceptance across various sectors 

Overview

Benzocaine is an ester local anesthetic. It is often used as a topical pain reliever. This is why it is found in cough drops like Orajel. It is also a common ingredient in many over-the-counter anesthetic ointments and products for oral ulcers. In addition to its medicinal use, benzocaine can also have a negative impact on the skin. Benzocaine is relatively non-toxic when used topically. It can cause anemia, a condition characterized by low hemoglobin levels. Therefore, it’s important to monitor the patient’s hematocrit during medical procedures. Although this condition is uncommon, it can result in unreliable readings on standard two-wavelength pulse oximeters. For safety reasons, benzocaine is typically diluted into single sprays.

Competitive Landscape

Major companies contributing to the global benzocaine market include Indofine Chemical Co., Ltd., Penta International Corporation, Alfa Aesar, Merck KGaA, Fengchen Group Co., Ltd, TCI Chemicals (India) Pvt. Ltd., Mahendra Chemicals, ACETO Corporation, Changzhou Sunlight Pharmaceutical Raw Material Co., Ltd, abcr GmbH, and Jinzhou Jiutai Pharmaceutical Co., Ltd.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4249

Drivers

Increasing adoption of benzocaine drugs to improve oxygen carrying capacity in patients suffering from methemoglobinemia and hemolysis is expected to augment the growth of the benzocaine market during the forecast period.

Moreover, wider acceptance in post-surgical pain management therapies owing to its non-irritation properties is expected to supplement the growth of the benzocaine market over the forecast period.

The Epitome of the COVID-19 Aftermath

COVID-19 prevalence has accelerated the adoption of benzocaine drugs across the healthcare sector. Benzocaine is also used to treat hemolysis. It works by binding to sodium channels in nerve cells. These sodium channels are responsible for carrying oxygen throughout the body. Consequently, COVID-19 patients can’t effectively release oxygen from their blood. In addition to this, crisis-fueled adoption of these drugs is on the rise, indicating long-term benefits for the global benzocaine market.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐫 𝐐𝐮𝐞𝐫𝐲 𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐛𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠, 𝐕𝐢𝐬𝐢𝐭 𝐚𝐭 – https://www.coherentmarketinsights.com/insight/talk-to-analyst/4249

Key Takeaways

• The benzocaine market is anticipated to grow at a CAGR of 2.70 % during the forecast period owing to the increasing application of new products and growing investments in the pharmaceutical sector. For instance, in November 2021, Mucinex launched Mucinex InstaSoothe, a range of pain relievers containing methanol and benzocaine, to manage sore throat irritation and pain.

• Across the geographical horizons, the North American region is a major destination for the global benzocaine market in view of the increasing approval rates of various products to cater to the mounting cardiovascular disease caseload.
• In the runner-up spot, the European region is another profit hub for the global benzocaine market on account of growing demand for at-home treatment solutions for elderly patients combined with its robust healthcare infrastructure.